Technical Analysis for QDEL - Quidel Corporation

Grade Last Price % Change Price Change
B 153.48 6.26% 9.04
QDEL closed up 6.26 percent on Friday, September 17, 2021, on 1.78 times normal volume. The stock crossed above its 200 day moving average, improving its long-term outlook by crossing above that critical trendline. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up
Historical QDEL trend table...

Date Alert Name Type % Chg
Crossed Above 200 DMA Bullish 0.00%
Expansion Breakout Bullish Swing Setup 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Stochastic Reached Overbought Strength 0.00%
Multiple of Ten Bullish Other 0.00%
Wide Bands Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
Wide Bands Range Expansion 6.26%
Pocket Pivot Bullish Swing Setup 4.33%
Wide Bands Range Expansion 4.33%
Older End-of-Day Signals for QDEL ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Up 5% 1 day ago
Rose Above 200 DMA 1 day ago
200 DMA Resistance 1 day ago
Up 1 ATR 1 day ago
Up 3% 1 day ago
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Quidel Corporation Description

Quidel Corporation develops, manufactures, and markets diagnostic testing solutions for applications in infectious diseases, women's health, and gastrointestinal diseases. The company's products for infectious diseases include QuickVue influenza test to detect viral antigens of influenza type A and B; QuickVue Strep A tests to detect Group A Streptococcal antigen from throat swabs or confirmation of presumptive Group A Streptococcal colonies recovered from culture; QuickVue RSV test, a rapid immunoassay for respiratory syncitial virus; and cell culture and DFA detection solutions to detect seven viral respiratory pathogens. It also offers cell-based products in various formats, including tubes, shell vials, and multi-well plates to culture and test for human viruses; ELVIS HSV system for the isolation and detection of herpes simplex virus (HSV) types 1 and 2; and a multiplex cell culture solution to isolate HSV, varicella zoster virus, and cytomegalovirus, as well as provides various analyzers and molecular assays. The company's products for women's health consist of QuickVue and RapidVue pregnancy tests to detect human chorionic gonoadotropin in serum or urine for the early detection of pregnancy; Thyretain for the diagnosis of graves, an autoimmune disease; QuickVue Chlamydia test to detect chlamydia trachomatis from endocervical swab and cytology brush specimens; and clinical and research products for the assessment of osteoporosis and the evaluation of bone resorption/formation, including metabolic bone markers to monitor the effectiveness of therapy in pharmaceutical and related research. In addition, it provides a fecal immunochemical test to detect the presence of blood in stool specimens; indirect fluorescent antibody products; and Helicobacter pylori tests, as well as develops diagnostic and research products in the fields of oncology, bone health, and autoimmune diseases. The company was founded in 1979 and is headquartered in San Diego, California.


Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Medicine Infectious Diseases Autoimmune Diseases Bone Gastrointestinal Autoimmune Disease Influenza Multiplex Lab Testing Viruses Gastrointestinal Disease Immunoassay Gastrointestinal Diseases Osteoporosis Herpes Herpes Simplex Search Products Herpes Simplex Virus Research Products Body Products Sexually Transmitted Diseases And Infections Cell Culture Chlamydia Varicella Antibody Products Clinical Pathology Detection Solutions Diagnostic And Research Products Helicobacter Testing Solutions

Is QDEL a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 288.7
52 Week Low 103.34
Average Volume 654,859
200-Day Moving Average 150.25
50-Day Moving Average 133.09
20-Day Moving Average 135.77
10-Day Moving Average 144.59
Average True Range 5.97
ADX 29.33
+DI 35.87
-DI 14.82
Chandelier Exit (Long, 3 ATRs) 136.97
Chandelier Exit (Short, 3 ATRs) 130.34
Upper Bollinger Bands 156.66
Lower Bollinger Band 114.88
Percent B (%b) 0.92
BandWidth 30.78
MACD Line 5.54
MACD Signal Line 3.92
MACD Histogram 1.6199
Fundamentals Value
Market Cap 6.46 Billion
Num Shares 42.1 Million
EPS 8.54
Price-to-Earnings (P/E) Ratio 17.98
Price-to-Sales 8.70
Price-to-Book 9.96
PEG Ratio 7.19
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 168.33
Resistance 3 (R3) 167.15 161.01 165.86
Resistance 2 (R2) 161.01 157.23 161.61 165.03
Resistance 1 (R1) 157.25 154.90 159.13 158.43 164.20
Pivot Point 151.11 151.11 152.06 151.71 151.11
Support 1 (S1) 147.35 147.33 149.23 148.53 142.76
Support 2 (S2) 141.21 145.00 141.81 141.93
Support 3 (S3) 137.45 141.21 141.11
Support 4 (S4) 138.63